Press Releases
-
CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service
-
Clinical Data Management: What Are The Key Challenges And How To Navigate Them?
In this post, learn about key challenges of clinical data management face and see what the future holds for CDMS System
Jun 30, 2022
-
Innovative Impurity Isolation and Identification Techniques at BOC Sciences to Address Pharmaceutical Impurity Issues
BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.
Jun 29, 2022
-
Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies
-
Aspergillus Species Fermentation Platforms: Suit The Needs in Scale-up and cGMP Fermentation
-
Creative Biogene Provides Support for The Entire Adenovirus Construction and Virus Packaging
-
Y2H cDNA Library Screening Service: Supporting Gene Functional Analysis and Potential Drug Target Discovery
-
Creative Bioarray Develops Customized Approaches of Immunohistochemistry Services to Accelerate Biological Projects
-
Creative Bioarray Develops Viable Medthods to Support Stem Cell Generation
-
Creative Bioarray Provides Comprehensive iPSC Characterization Service to Support Stem Cell Research
-
Saama Technologies Announces Appointment of New CEO Vivek Sharma
#1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO.
Jun 27, 2022
-
PHASTAR Names Chris Schoonmaker as Chief Operations Officer
PHASTAR Names Chris Schoonmaker as Chief Operations Officer London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.
Jun 28, 2022
-
FIRST CE-MARKED NAD+ ANALYSIS KIT TO THE MARKET
NADMED brings two kits to the market: Q-NADMED and Q-NAD.
Jun 28, 2022
-
Sharp Adds New Talent in Global Operations and Finance to Senior Leadership Team
-
Creative BioMart Microbe Performs Biofilm Testing and Research for Different Applications
-
BOC Sciences Demonstrates Comprehensive Strength with LYTAC Technology
BOC Sciences demonstrates its comprehensive strength with innovative LYTAC degradation technology solutions developed in the field of targeted protein degradation.
Jun 27, 2022
-
One-stop Mitochondria-focused Testing Services Targeting to Preclinical Studies of Cardiac Diseases
Creative Biogene offers one-stop mitochondria-focused testing services for the evaluation of a variety of cardiac diseases associated with mitochondrial dysfunction.
Jun 27, 2022
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Food Metabolomics Service
-
Creative Proteomics Lipidomics Introduces Glycerophospholipids Analysis Service
-
Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay